Repurposed Eflornithine (Norgine/US WorldMeds)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameRepurposed Eflornithine (Norgine/US WorldMeds)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrnithine decarboxylase inhibitors
TargetsOrnithine decarboxylase
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEuropeAustralia and New ZealandNew Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNorgine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNorgine LtdUSWM LLC
Inactive CompaniesN/A
Active IndicationsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A